This Website has a limited use of cookies. By using this website, you are agreeing to the terms and conditions listed in our data protection policy. Read more

Working Paper No. 1428

The Importance of the First Generic Substitution: Evidence from Sweden

Working Paper
Reference
Janssen, Aljoscha and David Granlund (2022). “The Importance of the First Generic Substitution: Evidence from Sweden”. IFN Working Paper No. 1428. Stockholm: Research Institute of Industrial Economics (IFN).

Authors
Aljoscha Janssen, David Granlund

We analyze changes in the willingness to substitute from prescribed pharmaceuticals to more affordable generic equivalents in response to the first experience with a substitution. Using Swedish individual-level data of prescribed and dispensed pharmaceuticals, we employ a dynamic event study and an instrumental variable approach to show that an initial substitution reduces the probability of opposing subsequent substitutions by 39 percentage points. The impact of a first substitution is especially large among elderly patients. We recommend that policy-makers target patients with a history of opposed substitution and offer additional discounts to promote substitution as long-term savings outweigh one-time costs.